CSL (Germany) Top Insiders
| CSJA Stock | EUR 20.60 0.60 2.83% |
CSL employs about 29.9 K people. The company is managed by 11 executives with a total tenure of roughly 69776 years, averaging almost 6343.0 years of service per executive, having 2718.55 employees per reported executive. Examination of CSL's management performance can provide insight into the company performance.
| Paul McKenzie CEO CEO MD |
| BEng CPA CEO MD CEO |
CSL |
CSL Management Team Effectiveness
The company has return on total asset (ROA) of 0.0658 % which means that it generated a profit of $0.0658 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0666 %, meaning that it generated $0.0666 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 39.1 B. The current Non Current Assets Total is estimated to decrease to about 25.8 BThe current Common Stock Shares Outstanding is estimated to decrease to about 531.2 MCSL holds a total of 970.3 Million outstanding shares. Almost 99.99 percent of CSL outstanding shares are held by general public with 0.011 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as CSL in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CSL, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
CSL Workforce Comparison
CSL LTD SPONADR is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2.26 Million. CSL claims roughly 29,904 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32. CSL LTD SPONADR Benchmark Summation
The output start index for this execution was one with a total number of output elements of sixty. The Lowest value over a specified period line plots minimum value of CSL LTD SPONADR price series.
CSL Notable Stakeholders
A CSL stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CSL often face trade-offs trying to please all of them. CSL's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CSL's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Paul McKenzie | CEO MD | Profile | |
| BEng CPA | MD CEO | Profile | |
| Mary Oates | Executive COO | Profile | |
| Chris Cooper | Head Relations | Profile | |
| Herve Gisserot | Executive Management | Profile | |
| Andy Schmeltz | Chief Officer | Profile | |
| BS BS | Executive Counsel | Profile | |
| Roanne Parry | Chief Officer | Profile | |
| Deirdre BeVard | Senior Operations | Profile | |
| Ken Lim | Chief Officer | Profile | |
| MPH MD | Executive Officer | Profile |
About CSL Management Performance
The success or failure of an entity such as CSL LTD SPONADR often depends on how effective the management is. CSL management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CSL management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CSL management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. CSL LTD operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
CSL Workforce Analysis
Traditionally, organizations such as CSL use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CSL within its industry.CSL Manpower Efficiency
Return on CSL Manpower
| Revenue Per Employee | 515.2K | |
| Revenue Per Executive | 1.4B | |
| Net Income Per Employee | 60.2K | |
| Net Income Per Executive | 163.6M | |
| Working Capital Per Employee | 235.3K | |
| Working Capital Per Executive | 639.5M |
Complementary Tools for CSL Stock analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |